Ois Podcast
Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye Trials
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:17:44
- Mais informações
Informações:
Sinopse
Eleven Biotherapeutics capitalized on exciting technology and promising clinical results for its lead Dry Eye product to stage a successful IPO in 2014. Abbie C. Celniker, PhD, President and CEO, talks frankly about her leadership style, dealing with public investors, and how she’s man-aging high expectations for lead product EBI-005.
